Cargando…
Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid
BACKGROUND: B cell depleting therapy is widely used for lymphoproliferative diseases and immune-mediated disorders, including mucous membrane pemphigoid. The latter is an autoimmune blistering disease affecting predominantly the mucosae potentially associated with devastating complications. METHODS:...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107448/ https://www.ncbi.nlm.nih.gov/pubmed/30141181 http://dx.doi.org/10.1186/s12348-018-0153-8 |